(Updated - October 16, 2015 3:04 PM EDT)

(Update corrects name of firm to FBR. FBR downgraded Zafgen (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View Analyst PT Change Downgrades

RBC Capital Sees Attractive Risk/Reward in Zafgen (ZFGN)October 19, 2015 10:13 AM Cowen Cuts Price Target on Zafgen (ZFGN) as Beloranib is Placed on Hold Following Patient Death October 16, 2015 1:28 PM Zafgen (ZFGN) PT Cut to $46 at Leerink Partners Amid Partial Clinical Hold; Maintains Bullish ViewOctober 16, 2015 12:07 PM Zafgen's (ZFGN) Beloranib Placed on Partial Clinical Hold by FDAOctober 16, 2015 6:31 AM Zafgen Announces Partial Clinical Hold Affecting Beloranib TrialsOctober 16, 2015 6:30 AM